Clinical Trials Browser

Adenocarcinoma × Docetaxel × 90 days × Clear all

NCT06592924 2026-01-14

TRIPLE-SWITCH

Phase 3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT06908304 2026-01-12

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

Phase 3 Recruiting

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT07316686 2026-01-05

Lutécio

Phase 1 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms